We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$61.5B
1-Year Est. Return
30.7%
This Fund
S&P 500
This Quarter
Est. Return
+6.3%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$31.9B
AUM Growth
+$1.95B
(+6.5%)
Cap. Flow
+$433M
Cap. Flow
% of AUM
1.36%
Top 10 Holdings %
Top 10 Hldgs %
19.72%
Holding
2,075
New
328
Increased
694
Reduced
841
Closed
117
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$152M |
| 2 |
Ventas
VTR
|
+$139M |
| 3 |
Williams Companies
WMB
|
+$122M |
| 4 |
Healthpeak Properties
DOC
|
+$100M |
| 5 |
Chevron
CVX
|
+$78.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$276M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$110M |
| 3 |
Fortune Brands Innovations
FBIN
|
+$84.2M |
| 4 |
AGN
Allergan Inc
AGN
|
+$73.4M |
| 5 |
Morgan Stanley
MS
|
+$66.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.6% |
| 2 | Consumer Staples | 12.46% |
| 3 | Energy | 12.05% |
| 4 | Financials | 8.62% |
| 5 | Utilities | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALR
501
DELISTED
Alere Inc
ALR
| $8.28M | 0.03% |
221,172
-6,279
| -3% | -$224K |
|
502
City Holding Co
CHCO
$2.05B
| $8.26M | 0.03% |
182,960
-4,716
| -3% | -$206K |
|
503
Dillards
DDS
$9.2B
| $8.23M | 0.03% |
70,592
+10
| +0% | +$1.04K |
|
504
General Dynamics
GD
$103B
| $8.16M | 0.03% |
69,992
+16,250
| +30% | +$1.85M |
|
|
SPPI
505
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $8.15M | 0.03% |
1,002,860
-27,785
| -3% | -$211K |
|
506
Amgen
AMGN
$209B
| $8.15M | 0.03% |
68,882
-41,780
| -38% | -$4.84M |
|
507
Labcorp
LH
$25.2B
| $8.13M | 0.03% |
92,398
-4,075
| -4% | -$353K |
|
508
Oceaneering
OII
$4.64B
| $8.11M | 0.03% |
103,734
-6,111
| -6% | -$448K |
|
509
KLA
KLAC
$222B
| $8.1M | 0.03% |
1,115,000
-516,470
| -32% | -$3.43M |
|
510
RPM International
RPM
$13.8B
| $8.08M | 0.03% |
174,917
-1,688
| -1% | -$73.1K |
|
511
Williams-Sonoma
WSM
$27.5B
| $8.07M | 0.03% |
224,904
-2,840
| -1% | -$93.4K |
|
|
ANFI
512
DELISTED
AMIRA NATURE FOODS LTD
ANFI
| $8.06M | 0.03% |
588,991
| – | – |
|
|
CPRX
513
DELISTED
Catalyst Pharmaceutical
CPRX
| $8.06M | 0.03% |
3,185,000
-82,000
| -3% | -$175K |
|
|
ESRX
514
DELISTED
Express Scripts Holding Company
ESRX
| $8.05M | 0.03% |
116,123
-1,564,247
| -93% | -$110M |
|
|
USG
515
DELISTED
Usg
USG
| $8.03M | 0.03% |
266,620
-7,565
| -3% | -$231K |
|
|
PE
516
DELISTED
PARSLEY ENERGY INC
PE
| $8.02M | 0.03% |
+333,200
| New | +$7.94M |
|
517
Merit Medical Systems
MMSI
$4.82B
| $8.02M | 0.03% |
531,032
-15,230
| -3% | -$211K |
|
|
VRNT
518
DELISTED
Verint Systems
VRNT
| $8.01M | 0.03% |
320,697
-9,148
| -3% | -$215K |
|
519
Roper Technologies
ROP
$40.4B
| $8.01M | 0.03% |
54,867
+190
| +0.3% | +$26.5K |
|
520
Unisys
UIS
$252M
| $7.95M | 0.02% |
321,137
-15,704
| -5% | -$397K |
|
521
Agios Pharmaceuticals
AGIO
$2.08B
| $7.91M | 0.02% |
172,700
-56,850
| -25% | -$2.32M |
|
522
Assurant
AIZ
$13.9B
| $7.89M | 0.02% |
120,397
+5,134
| +4% | +$343K |
|
523
Electronic Arts
EA
$52.4B
| $7.88M | 0.02% |
219,804
+20,883
| +10% | +$678K |
|
524
Walker & Dunlop
WD
$1.73B
| $7.85M | 0.02% |
556,100
-18,000
| -3% | -$275K |
|
|
RNET
525
DELISTED
RigNet, Inc.
RNET
| $7.83M | 0.02% |
+145,552
| New | +$7.29M |
|
Similar funds
Federated Hermes's Q2 2014 Portfolio in Review
As of Q2 2014, Federated Hermes held 2,075 positions worth $31.9B, up 6.5% from $29.9B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Federated Hermes's Q2 2014 filing shows 328 new, 694 increased, 841 reduced and 117 closed positions. Its largest new stake was ATHLON ENERGY INC COM: 939,555 shares worth $44.8M. The largest sale was AstraZeneca, an estimated $276M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Consumer Staples and Energy.
- Federated Hermes's largest Q2 2014 buy was ATHLON ENERGY INC COM: 939,555 shares worth $44.8M.
- Federated Hermes added most to Illumina in Q2 2014, an estimated $152M increase.
- Federated Hermes's biggest Q2 2014 reduction was AstraZeneca, cutting an estimated $276M.
- Federated Hermes fully exited SIEMENS AKTIENGESELLSCHAFT ADS in Q2 2014, selling an estimated $39.7M.
- Federated Hermes's ten largest holdings make up 20% of its $31.9B portfolio in Q2 2014.
- Federated Hermes opened 328 new positions and closed 117 in Q2 2014.
- Federated Hermes's portfolio value rose 6.5% quarter-over-quarter to $31.9B.
Based on Federated Hermes's 13F filing for Q2 2014, filed 7 Aug 2014.